University of Oxford scientists have reportedly developed the first malaria vaccine which, in a trial, surpassed a key goal of greater than 75 percent efficacy.
In a trial consisting of 450 children in Burkina Faso between the ages of five and 17 months, this vaccine candidate was shown to be 77 percent effective against malaria, Bloomberg reports. It also showed a "favorable safety profile and was well-tolerated." The study was published in The Lancet, though it has not yet been peer-reviewed, and the vaccine is set to be studied further in larger clinical trials with 4,800 children in four African countries.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"An effective and safe malaria vaccine would be a hugely significant extra weapon in the armory needed to defeat malaria," Malaria No More U.K.'s Gareth Jenkins said. "Countries freed from the malaria burden will be much better equipped to fight off new disease threats when they inevitably emerge in the future."
Adrian Hill, director of the University of Oxford's Jenner Institute, also told BBC News that the trial suggests this vaccine "has the potential to have a major public health impact."
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
